Pharma Firms Stir OTC Market, FDA Hones Enforcement: Top Stories Of 2009
This article was originally published in The Tan Sheet
Firms entering or expanding their presence in the OTC drug and nutritional product markets as part of pharmaceutical industry shuffling in 2009 attracted the attention of stakeholders already competing in those markets
You may also be interested in...
Sanofi-Aventis' $1.9 billion bid for OTC and personal care product firm Chattem offers the French firm a coveted toehold in the sizeable U.S. consumer health care market while also opening potential opportunities in emerging markets
Merck's Schering-Plough Consumer HealthCare Products division will launchZegerid OTC in the first half of 2010 as the first dual-ingredient OTC proton pump inhibitor
Experts disagree whether creative co-packaging of OTC drugs and dietary supplements is a legitimate alternative to problematic combination products or simply another regulatory quagmire